Home

Shetland Indígena Vacante sof ldv niebla Continental Heredero

Real-world effectiveness of 8-week treatment with ledipasvir/sofosbuvir in  chronic hepatitis C - ScienceDirect
Real-world effectiveness of 8-week treatment with ledipasvir/sofosbuvir in chronic hepatitis C - ScienceDirect

Informe de Posicionamiento Terapéutico de ledipasvir/sofosbuvir (Harvoni®)
Informe de Posicionamiento Terapéutico de ledipasvir/sofosbuvir (Harvoni®)

Efficacy and tolerability of interferon‑free regimen for patients with  genotype‑1 HCV infection
Efficacy and tolerability of interferon‑free regimen for patients with genotype‑1 HCV infection

Informe d'avaluació de resultats del tractament antiviral de l'hepatitis C  a l'any 2018
Informe d'avaluació de resultats del tractament antiviral de l'hepatitis C a l'any 2018

Treatment outcomes for SOF/LDV without RBV for HCV genotype 1 (1a, 1b,... |  Download Scientific Diagram
Treatment outcomes for SOF/LDV without RBV for HCV genotype 1 (1a, 1b,... | Download Scientific Diagram

Active hepatocellular carcinoma is an independent risk factor of  direct-acting antiviral treatment failure: A retrospective study with  prospectively collected data | PLOS ONE
Active hepatocellular carcinoma is an independent risk factor of direct-acting antiviral treatment failure: A retrospective study with prospectively collected data | PLOS ONE

EVALUACION DE LA EFICACIA Y SEGURIDAD DE LOS TRATAMIENTOS CON LOS NUEVOS  ANTIVIRALES DIRECTOS DEL VHC EN PACIENTES COINFECTADOS
EVALUACION DE LA EFICACIA Y SEGURIDAD DE LOS TRATAMIENTOS CON LOS NUEVOS ANTIVIRALES DIRECTOS DEL VHC EN PACIENTES COINFECTADOS

Tractament antiviral de l'hepatitis C crònica a l'any 2019, 2020 i 2021
Tractament antiviral de l'hepatitis C crònica a l'any 2019, 2020 i 2021

Informe de Posicionamiento Terapéutico de ledipasvir/sofosbuvir (Harvoni®)
Informe de Posicionamiento Terapéutico de ledipasvir/sofosbuvir (Harvoni®)

Resumenes AASLD-2016-GEHEP
Resumenes AASLD-2016-GEHEP

Sofosbuvir (SOF) Suppresses Ledipasvir (LDV)-resistant Mutants during SOF/ LDV Combination Therapy against Genotype 1b Hepatitis C Virus (HCV) |  Scientific Reports
Sofosbuvir (SOF) Suppresses Ledipasvir (LDV)-resistant Mutants during SOF/ LDV Combination Therapy against Genotype 1b Hepatitis C Virus (HCV) | Scientific Reports

Simulation plot predicting the probability of LDV-resistant mutant... |  Download Scientific Diagram
Simulation plot predicting the probability of LDV-resistant mutant... | Download Scientific Diagram

Effectiveness of Ledipasvir/Sofosbuvir with/without Ribavarin in Liver  Transplant Recipients with Hepatitis C
Effectiveness of Ledipasvir/Sofosbuvir with/without Ribavarin in Liver Transplant Recipients with Hepatitis C

Six weeks of sofosbuvir/ledipasvir (SOF/LDV) are sufficient to treat acute  hepatitis C virus genotype 1 monoinfection: The HepNet Acute HCV IV Study
Six weeks of sofosbuvir/ledipasvir (SOF/LDV) are sufficient to treat acute hepatitis C virus genotype 1 monoinfection: The HepNet Acute HCV IV Study

Respuestas para un nuevo abordaje de la hepatitis C
Respuestas para un nuevo abordaje de la hepatitis C

HCV-Trials.com : A regularly updated website with all most recent clinical  trials data in HCV infection
HCV-Trials.com : A regularly updated website with all most recent clinical trials data in HCV infection

Antiviral activity of LDV and SOF as monotherapy (A) and combination... |  Download Scientific Diagram
Antiviral activity of LDV and SOF as monotherapy (A) and combination... | Download Scientific Diagram

ION-3 Study: LDV/SOF + RBV for naïve genotype 1 - ppt download
ION-3 Study: LDV/SOF + RBV for naïve genotype 1 - ppt download

Treatment groups by regimen. SOF, sofosbuvir; LDV, ledipasvir; SIM,... |  Download Scientific Diagram
Treatment groups by regimen. SOF, sofosbuvir; LDV, ledipasvir; SIM,... | Download Scientific Diagram

Cost-utility Analysis of Second-generation Direct-acting Antivirals for  Hepatitis C | Hepatitis Monthly | Full Text
Cost-utility Analysis of Second-generation Direct-acting Antivirals for Hepatitis C | Hepatitis Monthly | Full Text

RASs found pre- and post-treatment with LDV/SOF + RBV detected as low... |  Download Scientific Diagram
RASs found pre- and post-treatment with LDV/SOF + RBV detected as low... | Download Scientific Diagram

Combinación de ledipasvir/sofosbuvir como tratamiento de la infección  crónica por hepatitis C | Anales de Pediatría
Combinación de ledipasvir/sofosbuvir como tratamiento de la infección crónica por hepatitis C | Anales de Pediatría

Real-life data on potential drug-drug interactions in patients with chronic  hepatitis C viral infection undergoing antiviral therapy with  interferon-free DAAs in the PITER Cohort Study | PLOS ONE
Real-life data on potential drug-drug interactions in patients with chronic hepatitis C viral infection undergoing antiviral therapy with interferon-free DAAs in the PITER Cohort Study | PLOS ONE